Total Valuation
Profound Medical has a market cap or net worth of $240.99M. The enterprise value is $157.64M.
Market Cap$240.99M
Enterprise Value$157.64M
Share Statistics
Profound Medical has 36,337,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,337,640
Owned by Insiders2.97%
Owned by Institutions35.08%
Financial Efficiency
Profound Medical’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -31.11%.
Return on Equity (ROE)-0.65
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-31.11%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee115.35K
Profits Per Employee-299.79K
Employee Count142
Asset Turnover0.12
Inventory Turnover0.58
Valuation Ratios
The current PE Ratio of Profound Medical is ―. Profound Medical’s PEG ratio is -0.20.
PE Ratio―
PS Ratio14.48
PB Ratio3.58
Price to Fair Value3.58
Price to FCF-6.07
Price to Operating Cash Flow-6.27
PEG Ratio-0.20
Income Statement
In the last 12 months, Profound Medical had revenue of 16.38M and earned -43.32M in profits. Earnings per share was -1.43.
Revenue16.38M
Gross Profit11.59M
Operating Income-41.98M
Pretax Income-43.06M
Net Income-43.32M
EBITDA-41.41M
Earnings Per Share (EPS)-1.43
Cash Flow
In the last 12 months, operating cash flow was -38.32M and capital expenditures -179.08K, giving a free cash flow of -38.50M billion.
Operating Cash Flow-38.32M
Free Cash Flow-38.50M
Free Cash Flow per Share-1.06
Dividends & Yields
Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change8.98%
50-Day Moving Average6.80
200-Day Moving Average6.55
Relative Strength Index (RSI)45.34
Average Volume (3m)136.84K
Important Dates
Profound Medical upcoming earnings date is Jul 30, 2026, After Close (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Profound Medical as a current ratio of 12.52, with Debt / Equity ratio of 12.56%
Current Ratio12.52
Quick Ratio11.17
Debt to Market Cap0.02
Net Debt to EBITDA1.33
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Profound Medical has paid 256.41K in taxes.
Income Tax256.41K
Effective Tax Rate>-0.01
Enterprise Valuation
Profound Medical EV to EBITDA ratio is -4.40, with an EV/FCF ratio of -4.67.
EV to Sales11.12
EV to EBITDA-4.40
EV to Free Cash Flow-4.67
EV to Operating Cash Flow-4.69
Balance Sheet
Profound Medical has $50.33M in cash and marketable securities with $7.47M in debt, giving a net cash position of $42.86M billion.
Cash & Marketable Securities$50.33M
Total Debt$7.47M
Net Cash$42.86M
Net Cash Per Share$1.18
Tangible Book Value Per Share$2.19
Margins
Gross margin is 71.04%, with operating margin of -256.27%, and net profit margin of -264.44%.
Gross Margin71.04%
Operating Margin-256.27%
Pretax Margin-262.88%
Net Profit Margin-264.44%
EBITDA Margin-252.79%
EBIT Margin-256.27%
Analyst Forecast
The average price target for Profound Medical is $11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$11.00
Price Target Upside49.25% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast58.59%
EPS Growth Forecast-2.80%